Axa S.A. Immunome Inc. Transaction History
Axa S.A.
- $32.2 Billion
- Q4 2024
A detailed history of Axa S.A. transactions in Immunome Inc. stock. As of the latest transaction made, Axa S.A. holds 179,458 shares of IMNM stock, worth $1.82 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
179,458
Previous 179,741
0.16%
Holding current value
$1.82 Million
Previous $2.63 Million
29.92%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IMNM
# of Institutions
125Shares Held
45.7MCall Options Held
74KPut Options Held
2.04M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$55.7 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$48.9 Million3.87% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$39.3 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$38 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.46MShares$35 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $123M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...